Virtu Financial LLC Zymeworks Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$4.82 - $7.7 $63,956 - $102,171	13,269 New	13,269 $70,000
Q1 2021 May 19, 2021	SELL	$29.83 - $56.81 $138,411 - $263,598	-4,640 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$39.12 - $54.99 $181,516 - $255,153	4,640 New	4,640 $219,000
Q3 2020 Dec 11, 2020	SELL	$29.21 - $46.58 $448,870 - $715,794	-15,367 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$33.67 - $40.0 $517,406 - $614,680	15,367 New	15,367 $554,000
Q1 2018 May 14, 2018	SELL	$7.93 - $13.41 $93,407 - $157,956	-11,779 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$6.87 - $9.19 $80,921 - $108,249	11,779	11,779 $89,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.